Clarus closes $660m bio fund
This article was originally published in Clinica
Clarus Ventures has raised $660m for its second life sciences investment fund, Clarus II. The money will be invested over three years in medical technology, biotechnology and specialty pharmaceutical companies. Clarus said between $20-60m will be allocated to each portfolio company. The VC raised $500m in its first investment fund in late 2005 - to date, around 90% of the proceeds have been committed. Clarus Ventures has offices on the US east and west coast.